Search Results for "Leap Intrexon"
Matching Channels
None
Matching News
Oragenics, Intrexon in antibiotics deal
Oragenics Inc. (OTCBB:ORNI) jumped $1.28 (97%) to $2.60 after announcing a deal to use synthetic biology technology from Intrexon Corp. (Blacksburg, Va.) to develop and commercialize lantibiotics, whi...
Intrexon raises $150 million in F round
Synthetic biology company Intrexon Corp. (Blacksburg, Va.) raised $150 million in a series F round from undisclosed new investors and existing investors, including affiliates of Intrexon Chairman and...
Halozyme Licensing Deal Valued at $63M
San Diego’s Halozyme Therapeutics (NASDAQ: HALO) and Foster City, CA-based Intrexon have agreed to use Halozyme’s recombinant human hyaluronidase to develop an injectable formulation of an...
Intrexon, Synthetic Biologics in infectious disease deal
Intrexon Corp. (Blacksburg, Va.) granted Synthetic Biologics Inc. (NYSE-M:SYN) exclusive, worldwide rights to develop and commercialize mAbs for three undisclosed infectious disease indications using...
A number of stocks were upgraded and downgraded by equities research analysts today, as reported by Analyst Ratings Network (http://bit.ly/arndailyr) and Equity Briefing:Robert W. Baird downgraded sh...
ROCKVILLE, Md. and SAN FRANCISCO, Aug. 8, 2012 /- Synthetic Biologics, Inc. (NYSE Amex: SYN ), a developer of synthetic biologics and innovative medicines for unmet medical needs, and Intrexon...
A leap second will be introduced on June 30, 2012 following a decision made by the International Earth Rotation and Reference Systems Service earlier this year. This could potentially be one of the la...
Sanford-Burnham and Intrexon Corporation establish collaboration to accelerate stem cell research
(Sanford-Burnham Medical Research Institute) Under the agreement, Sanford-Burnham will gain access to sophisticated proprietary cellular selection and gene regulation technologies that are not current...
Matching PubMed Articles
Structural and functional analysis of human liver-expressed antimicrobial peptide 2.
Human liver-expressed antimicrobial peptide 2 (LEAP-2) is a cationic antimicrobial peptide (CAMP) believed to have a protective role against bacterial infection. Little is known about the structure-ac...
The effect of substrate compliance on the biomechanics of gibbon leaps.
The storage and recovery of elastic strain energy in the musculoskeletal systems of locomoting animals has been extensively studied, yet the external environment represents a second potentially useful...
Simulation methods with extended stability for stiff biochemical kinetics.
ABSTRACT: BACKGROUND: With increasing computer power, simulating the dynamics of complex systems in chemistry and biology is becoming increasingly routine. The modelling of individual reactions in (bi...
Laparoscopic resection of adrenal and extra-adrenal pheochromocytoma.
OBJECTIVES: Laparoscopic resection of extra-adrenal pheochromocytoma (EAPs) requires meticulous surgical procedures because of changes in anatomical disposition and/or proximity to major blood vessels...
